Category Archives: Cancer and neoplasms

Childhood cancer survivors face serious health hurdles later in life – US review

Researchers have warned that people who’ve had childhood cancer are highly likely to face physical and mental health challenges later in life, with 95% developing a “significant health problem” related to their cancer or treatment by the age of 45. The team reviewed 73 studies, including 39 cohort studies that followed patients over time, and […]

Multidisciplinary Team Approach Is Integral to Oncology Care

Julie M. Vose, MD, MBA gives an overview on the importance of multidisciplinary care in the oncology space. Treating and caring for patients with cancer can require a complex team of medical professionals who work together toward a common goal. This type of approach emerged in the 1980s with the addition of chemotherapy to radiotherapy […]

Novo Nordisk Halts Semaglutide Kidney Outcomes Trial for Early Efficacy

Credit: Fotolia Novo Nordisk has announced the decision to discontinue the FLOW trial based on a recommendation from the trial’s independent Data Monitoring Committee indicating an interim analysis of the kidney outcomes trial for weekly semaglutide had met certain prespecified criteria for stopping the trial early for efficacy. According to the October 10, 2023 announcement […]

Pharmacists have a vital role in shining a brighter light on blood cancer

Blood cancer is the fifth most common cancer and the third leading cause of cancer-related deaths in the UK but awareness of it is overshadowed by more widely recognised cancers​[1]​. According to the charity Blood Cancer UK, despite contributing to more deaths than breast cancer and prostate cancer, 78% of individuals grappling with blood cancer […]

City of Hope and TGen research reveals what potentially causes a leukemia to become more aggressive

•    Research focuses on chronic myeloid leukemia with the goal of creating a new therapy for patients•    Study funded by Robert & Lynda Carter Altman Family Foundation Research Fund CONTACTLetisia [email protected] LOS ANGELES — Scientists with City of Hope®, one of the largest cancer research and treatment organizations in the United States, and the Translational […]

Skin Disease Shown to Significantly Impact Daily, Work Lives Among Patients in Europe

Around half of individuals with a single skin disease report their condition being embarrassing in their work and personal life, according to a new analysis of the European general population, with sleep disturbances being prevalent for 30%–50% of those with psoriasis, rosacea, acne, atopic dermatitis, or urticaria.1 These new findings and more resulted from an […]

Ultra-fast deep-learned CNS tumour classification during surgery

Abstract Central nervous system tumours represent one of the most lethal cancer types, particularly among children1. Primary treatment includes neurosurgical resection of the tumour, in which a delicate balance must be struck between maximizing the extent of resection and minimizing risk of neurological damage and comorbidity2,3. However, surgeons have limited knowledge of the precise tumour […]

Genetic change may lead to more aggressive leukemia

Scientists with City of Hope® and the Translational Genomics Research Institute (TGen), part of City of Hope, may have discovered one of the reasons why a type of leukemia sometimes develops into a more aggressive form, according to recent research published in Nature Communications.  Guido Marcucci, M.D. Led by Guido Marcucci, M.D., City of Hope […]

Cancer slowly losing death sentence tag in Zimbabwe

Herbert Mutugwi Being diagnosed with cancer in Zimbabwe is generally viewed as the death penalty. Many people do not survive the effects of this debilitating, non-communicable disease. The southern African nation has around 15 million people whose behaviour change is usually due to witnessing real -life cases. Change to this perception has been slow due […]

High Serum LDH Levels Confer Worse Survival in Newly Diagnosed AML

“LDH is a potent biochemical marker associated with lower response rates and poor survival in [patients with] AML,” according to the study authors. High serum lactate dehydrogenase (LDH) level appeared to be a poor prognostic factor with respect to survival outcomes in a small cohort of patients with newly diagnosed acute myeloid leukemia (AML), according […]